Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 08:56 am Purchase |
2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
Deep Track Capital, LP | 4,000,000 7.810% |
143,537 (+3.72%) |
Filing History |
| 2022-02-14 08:55 am Purchase |
2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
RTW Investments, LP | 2,863,198 5.600% |
2,863,198 (New Position) |
Filing History |
| 2022-02-11 4:27 pm Purchase |
2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
ORBIMED ADVISORS LLC | 2,200,200 4.300% |
2,200,200 (New Position) |
Filing History |
| 2022-02-10 09:28 am Sale |
2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
-2,768,840 (Position Closed) |
Filing History |
| 2021-09-01 4:20 pm Purchase |
2021-08-31 | 13G | Jounce Therapeutics, Inc. JNCE |
Deep Track Capital, LP | 3,856,463 7.530% |
3,856,463 (New Position) |
Filing History |
| 2021-04-05 5:26 pm Purchase |
2019-11-20 | 13G | Jounce Therapeutics, Inc. JNCE |
BRISTOL MYERS SQUIBB CO BMY |
3,456,463 7.600% |
3,456,463 (New Position) |
Filing History |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
Third Rock Ventures II L.P. | 12,339,828 31.000% |
-939,292 (-7.07%) |
Filing History |
| 2021-02-01 2:13 pm Purchase |
2021-01-20 | 13G | Jounce Therapeutics, Inc. JNCE |
PFM Health Sciences, LP | 2,388,067 6.000% |
2,388,067 (New Position) |
Filing History |
| 2021-01-29 4:12 pm Purchase |
2021-01-19 | 13G | Jounce Therapeutics, Inc. JNCE |
ADAGE CAPITAL PARTNERS GP LLC | 2,768,840 6.950% |
2,768,840 (New Position) |
Filing History |
| 2020-10-26 4:33 pm Purchase |
2020-10-16 | 13G | Jounce Therapeutics, Inc. JNCE |
GILEAD SCIENCES INC GILD |
5,539,727 13.900% |
5,539,727 (New Position) |
Filing History |